Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

HARVARD BIOSCIENCE INC Director's Dealing 2014

Jun 16, 2014

34975_dirs_2014-06-16_1e385da7-63bf-41b9-ab9a-4f959f6b5494.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: HARVARD BIOSCIENCE INC (HBIO)
CIK: 0001123494
Period of Report: 2014-06-16

Reporting Person: Gagnon Robert E. (Chief Financial Officer)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2014-06-16 Common Stock P 5000 $3.855 Acquired 5000 Direct

Footnotes

F1: This transaction was executed in two trades at $3.85 and $3.8593. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.